文献速递浆细胞疾病MDS 与骨髓增殖性肿瘤

老年人群中意义未明单克隆丙种球蛋白病与克隆性造血显示无关的临床和生物学轨迹

MGUS and clonal hematopoiesis show unrelated clinical and biological trajectories in an older population cohort.
PubMed 文献 · Blood Adv · 2022-01-01

在777名中位年龄91岁的老年受试者中,意义未明单克隆丙种球蛋白病(MGUS)患病率为9.6%,克隆性造血(CH)为17.3%;MGUS患者中CH检出率为9.7%,CH患者中MGUS检出率为5.5%;两者无显著相关性,且与临床和实验室协变量的关联不同,提示可能代表年龄相关的无关克隆漂移;需验证性研究评估CH在浆细胞疾病中的意义。

要点

  • 老年人群(中位年龄91岁)中MGUS患病率9.6%,CH患病率17.3%。
  • MGUS与CH的存在无显著相关性。
  • 两者与临床和实验室协变量的关联不同,提示为年龄相关的无关克隆漂移。

核心结论

  • MGUS与CH在老年人群中无显著相关性,且与临床和实验室协变量的关联不同,提示两者可能代表年龄相关的无关克隆漂移。
  • 需要验证性研究评估CH在浆细胞疾病中的相关性。

研究设计与样本

  • 对777名老年受试者(中位年龄91岁)先前筛查CH的完全临床注释数据集进行分析。
  • 该试验在www.clinicaltrials.gov注册,注册号为NCT03907553。

主要发现

  • MGUS患病率为9.6%,CH患病率为17.3%。
  • MGUS患者中CH检出率为9.7%,CH患者中MGUS检出率为5.5%。
  • 未发现MGUS与CH的存在之间存在显著相关性。
  • MGUS与CH两种状况与临床和实验室协变量表现出不同的关联。

局限性

  • 需要验证性研究评估CH在浆细胞疾病中的相关性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Monoclonal gammopathy of undetermined significance (MGUS) and clonal hematopoiesis (CH) are 2 preclinical clonal expansions of hematopoietic cells whose prevalence rises with age, reaching almost 10% in people of aged 70 years and older. The increased risk of myeloid malignancies in patients with myeloma is well defined, and the study of the association between CH and MGUS could help explain this phenomenon. Here, we analyzed a fully clinically annotated dataset of 777 older subjects (median age, 91 years) previously screened for prevalence of CH. The prevalence of MGUS and CH was 9.6% and 17.3%, respectively. We detected CH in 9.7% of the patients with MGUS and MGUS in 5.5% of the patients with CH. We did not find a significant correlation between the presence of MGUS and CH. Furthermore, the 2 conditions showed a differential association with clinical and laboratory covariates, suggesting that MGUS and CH may represent age-associated unrelated clonal drifts of hematopoietic cells. Confirmatory studies are needed to assess the relevance of CH in plasma cell disorders. This trial was registered at www.clinicaltrials.gov as #NCT03907553.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Da Vià MC, Lionetti M, Marella A, et al. MGUS and clonal hematopoiesis show unrelated clinical and biological trajectories in an older population cohort. Blood Adv. 2022. PMID: 35390146. doi:10.1182/bloodadvances.2021006498

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。